Should I resist the temptation to buy falling stars?
Exploring Stockopedia’s rankings recently, I felt a guilty temptation. A quick screen revealed that there were only 40 UK shares classified as Falling Stars. On that list were quite a few shares I’ve often thought I’d like to own.
For example, at the time of writing, the two largest companies on the Falling Stars list are drinks group Diageo (LON:DGE) and tool hire giant Ashtead (LON:AHT).
Other big names that caught my eye included Spirax (LON:SPX), Croda International (LON:CRDA) and Howden Joinery (LON:HWDN). And there were more. You can see the current list here.
Many of these companies have seen big share price falls in recent times:
Browsing through the list, I felt sure that some of them ought to offer value at current levels…
Did I hit buy and add any of these Falling Stars to my portfolio? More on that shortly. But first, I want to consider the type of company we’re likely to find labelled as a Falling Star and take a closer look at their historic performance.
Is there any data to support a more positive stance on these out-of-favour stocks?
Once again, my thanks go to Alex for crunching the numbers and producing these excellent charts.
What’s a Falling Star?
Falling Stars are a losing StockRank Style in the Stockopedia system:
Falling Stars are often glamour shares that have fallen out of fashion – often because their growth has stalled.
You can read a more detailed review here, but in short they tend to have low StockRanks and be characterised by a high quality rank, but low value and momentum scores.
For contrast, here’s an overview of the average StockRank and factor scores for the current crop of Super Stocks:
I think there probably are some long-term opportunities among the Falling Stars. But I also think there’s a Buffett quote that covers this situation:
I don’t look to jump over seven-foot bars; I look around for one-foot bars that I can step over - Warren Buffett
A lack of multiple positive factors means that finding winning opportunities among Falling Stars is likely to be more difficult than when hunting among winning styles.
Falling Stars can perform (sometimes)
The only infallible rule I know in investing is that it’s important to develop an approach that you both understand and are comfortable with.
Are there investors out there who successfully specialise in finding profitable opportunities among Falling Stars? Probably.
But as the chart below shows, beating the market with Super Stocks has been much easier over the last decade (Buffett's one-foot bars).
Falling Stars have underperformed the wider UK market on a 10-year view. Anyone beating the market by investing in these stocks has probably been very selective and had good timing:
Note: This chart compares an annually rebalanced portfolio of Super Stocks and Falling Stars. It does not include transaction costs and does not take into account stocks that may have fitted these styles at other points during each year.
However, it’s clear that there have been periods over the last decade when Falling Stars have outperformed. This chart highlights these more explicitly:
The most notable period of outperformance was during the pandemic, since when a dramatic correction has occurred.
The data suggest the Covid boom for Falling Stars may have been driven by the opportunity to buy quality stocks whose profitability was above average…
… at valuations that were below average:
This apparent buying opportunity was followed by a period of outperformance, as the era of cheap money delivered a final, indiscriminate burst of glory.
My reading of the subsequent slump in Falling Stars is that it reflects the post-pandemic reality of higher interest rates, inflation and sluggish economic growth. This has persuaded investors to become more discerning and seek stocks with stronger growth or value characteristics.
This cycle is perhaps well illustrated by drinks giant Diageo. This FTSE 100 stalwart was a Falling Star in April 2020 and remains so today.
However, having peaked at over £40, Diageo shares have since fallen by almost 50% and are now below the level seen in the March 2020 crash:
This de-rating has taken place even though profits are largely unchanged, as earnings estimates have drifted lower:
Is the worst over for Diageo? It’s an open question, as I discussed in my recent review of fund manager Terry Smith’s 2024 letter. Personally, I would be (much) more interested in Diageo if its balance sheet was not so heavily leveraged.
Are there any Falling Stars worth a closer look?
I think that any sensible factor-driven strategy should probably include the general assumption that Falling Stars are best avoided.
However, for investors who are keen to take a stock-picking approach and really dig deeper, I’ve taken another look at the current list. How would I find any potential opportunities?
Leveraging the StockRanks
If I was considering investing in a Falling Star, my aim would be to buy shares in a quality business as it’s emerging from a difficult period. In other words, a turnaround.
In such a scenario, I’d hope the business would have the potential to deliver operating leverage and a share price re-rating as it returned to growth.
Although making selections like this is definitely a stock-picking strategy rather than a systematic approach, I’d still aim to benefit from the StockRanks where possible.
Even mid-ranked stocks have outperformed the lowest-ranked shares over longer periods. This suggests to me that focusing on higher-ranked Falling Stars could still be worthwhile, especially if time available for research is limited:
I’d be inclined to focus my initial efforts on the top quartile of Falling Stars, in terms of StockRank.
At the time of writing that’s 10 companies, which is more manageable than trying to consider the whole list:
Using this short list, I’d then begin a more in-depth research process. Some of the factors I’d consider would be:
Does the underlying business show genuine quality? Does it have a durable competitive advantage and can it generate above-average returns?
Has something changed in the business in the last year or two?
Is there a strong balance sheet? Net cash or minimal debt can provide useful downside protection during difficult periods.
Valuation? I’d consider recent earnings, but perhaps also the 10-year average (CAPE 10y) valuation. Could the business be cheap if normalised trading conditions resume?
What about other valuation metrics - relative to assets, free cash flow or sales?
Model scenarios: for example, what impact would a 1% change in operating profit (+/-) have on profits? What about a 5% change in revenue? This could tell me something about both risk and opportunity.
Review recent trading and use this as context to critically consider broker forecasts. Read broker notes for extra insight if possible, especially with small caps.
Finally, look for any early signs that momentum might be about to turn positive.
A recent ahead of expectations trading update is sadly unlikely, as such a stock would probably no longer be a Falling Star.
However, other more subtle signals may exist. Stockopedia’s new Smart Money Playbook explains how investors can benefit from signals such as director dealing (preferably by C-suite execs) or fund manager moves.
This new report contains some excellent insights and is a valuable read, in my view.
Next steps
If my top 10 proved fruitless, then I might move further down the list (or shift my attention to a more favourable style!).
If I believed that I’d found an opportunity, I’d ask myself why I should invest in this business, rather than a company with a more favourable multi-factor outlook:
Even if there’s an opportunity here – is it the best opportunity for my capital?
Is the risk-reward balance favourable when compared to higher-ranked alternatives?
Some of my biggest investing losses have resulted from not evaluating the downside risks, both in terms of performance and valuation. A cheap share can always get cheaper.
Have I added any Falling Stars to my portfolio?
Quality doesn’t always last forever, but recognising when a company has lost its competitive advantage isn’t always easy. Unfortunately, there’s an opportunity cost to holding a losing position while waiting for a turnaround. We could be employing our capital more profitably elsewhere.
A further challenge is that managing such investments is made more difficult by our hard-wired psychological bias to loss aversion. This can make it harder to objectively recognise the correct time to let go.
From my perspective, the UK market offers plenty of buying opportunities at the moment. Although one of my long-term holdings has dropped to Fallen Star status, I have not bought any stocks with this style.
I don’t feel I need to take the extra risks of a solo factor rank stock, when there are other stocks on my watch list that score highly across a broader range of factors.
As always, I’d love to hear what you think. Are you tempted by the turnaround potential of Falling Stars?
Or do you prefer to avoid these often-complex situations, even at the potential cost of buying in at a higher price further down the line?
Disclaimer
This is not financial advice. Our content is intended to be used and must be used for information and education purposes only. Please read our disclaimer and terms and conditions to understand our obligations.


23 comments
I see Howden Joinery (LON:HWDN) are on the list, they soon went from Falling Star to High Flier.
Bought Ashtead (LON:AHT) recently despite Falling Star status. Improved forecast earnings, USA based providing scope for greater expansion and an institutional investor doubled its stake.
Personally prefer fallen stars to hit the ground and bounce a few times - which is a way of saying I wait until all the bad news is hopefully past and take a much longer view. I am not a chartist but double bottoms etc and waiting for a firm floor seems to help.
Capita (LON:CPI) has not been mentioned but that is possibly showing signs of life and the long term chart is wow !
Agree. Wait for turnaround to be confirmed.
Yep
In general I would never recommend that anyone should buy a share with low momentum. Mostly the share price will continue to decline. It's better to wait until the share price has stopped falling and is making small gains. That way you can avoid the loss and stand to gain more.
This is a very useful article and it reinforces one of my long standing golden rules of investing - don't buy Falling Stars and sell if a holding becomes one. As Diageo (LON:DGE), Bioventix (LON:BVXP) and many more illustrate, the underperformance can continue for a very long time.
I think it's one of the great strengths of Stockopedia, that it shows us whole swathes of stocks that may damage our portfolios and that we should probably simply ignore. Sure, there may well be the odd winner amongst them, but why fish in a pool of limited winners, when we can fish amongst the richer and more abundant waters of the Super Stocks, High Flyers and Contrarian stocks.
Thanks Roland really challenging article, it's interesting that these great companies have lost their way to become fallen stars, having loss that competitive edge. A spring clean of management is probably required to invigorate and find a new edge.
Great insightful article Rowland, many thanks. Whatever else I pay my subscription for (and despite some moaners who say they don't get content they want), your deep dive thoughtful articles that both teach me something and make me think about my investing are the jam on the top. Thanks to the whole team for the output of late
Thanks for this excellent article Roland.
How would you go about looking for falling stars that are beginning to transition into a turnaround situation?
As falling stars have high Q scores but low V & M scores then should we look for broker upgrades and therefore increasing M scores? However, how many falling stars transition into high flyers - maintenance of high quality and increased momentum score. I doubt many falling stars become turnaround because that would be a drop in Q and an increase in V & M?
Taking Diageo (LON:DGE) as an example, the Q rank is at 87 but the M rank has been edging up (+11 over 30 days) to 35 - brokers have very slightly upgraded. Perhaps this is stabilisation - things not getting any worse?
Is there a sweet spot where we can identify newly christened of the four winning styles and can this be screened?
Cheers!
EDIT - I see it can be screened!
DGE is an interesting share. Nick Train likes it a lot still, but Terry Smith doesn't.
Weight-loss drugs are on the rise, These drugs seem to have benefits in a large number of areas. I think Smith said it was the closest thing we are going to get to an elixir of life. One effect of the drugs is that people are inclined to drink less alcohol. This seems to have weighed heavily in Smith's thinking.
Nick Train doesn't seem concerned about this. He sees a great future in the upmarket brands that DGE makes.
There are a number of other headwinds with DGE.
It's interesting to see two titans in the business battle it out, and who will ultimately prevail.
I think folks sometimes misunderstand Terry Smith's approach a little. He is very cautious about business risk. He sold Estee Lauder, for example, disliking the way they handled the supply chain in China.
Smith has been criticised for not owning companies like NVDA. Well, that's not the way he operates. Smith isn't out to beat the market year after year, but over an extended period. He also seems somewhat sensitive to volatility in share price, which might surprise people. Shares shouldn't be a roller-coaster ride.
Personally I think that the weight loss drugs are a red herring and will not impact sales. However, I do feel that we are drinking less on average. Diageo (LON:DGE) only has a small total market share and some top brands and the argument is that people are drinking less but opting for premium brands, which should help Diageo. Also, Guinness and Guinness Zero are going great guns as is Tequila although I am not sure how the tariffs impact these, especially the Tequila which I assume comes from Mexico??
I agree about weight loss drugs, they could have the opposite effect, ie people could drink more and not put on weight. Diageo is an international brand, what happens in the US May not apply to other countries. I agree young people don't seem to drink like we did in younger years. That may partly be down to prices. Drink was cheap in pubs 50 years ago but not now. I rarely drink in pubs now.
"Nick Train likes it a lot still, but Terry Smith doesn't."
Well Smith did hold Diageo (LON:DGE) for 15 years. He has underperformed the market for 4 years running.
Weight loss drug companies could get hammered by Trump, see Novo Nordisk A/S (NYQ:NVO) one of Terry Smith's favourites but the shares have almost halved recently.
Fundsmith has annualised 14.9% since inception. What's the relevance of an arbitrary four year period? As for Novo, Fundsmith bought this long before weight loss drugs. I find the antipathy to Terry Smith rather strange. Give me Smith over Woodford any day of the week. Smith does what he says he will do. Woodford did exactly what he said he wouldn't do and the results speak for themselves.
The 4 years are the last 4 years, maybe he has lost the plot, like some other fund managers did. Considering his fund is over 70% in US stocks, very disappointing performance. He has made many mistakes in the last few years, Diageo (LON:DGE) is just one, PayPal Holdings (NSQ:PYPL) was another, Adobe (NSQ:ADBE) another.
Maybe his personal problems are affecting him?
Yes Woodford was considered good at one time, never invested in any of his funds.
Terry Smith did say that more quality brands would be drank and he changed his drinks investment to reflect this consumer change
It is interesting to listen to podcasts featuring both Terry Smith and Nick Train, have done this over the last few years. N Train sounds like he has almost lost his way at times where as Terry Smith seems to be very much in his groove. At least that's the impression I get. Nick Train has taken some rather drastic steps recently so it will get more interesting from now.
Result of this I have purchased Fundsmith over recent years but not Nick Trains funds.
And re Fundsmith's performace given its US bias, I do feel he is taking a risk managed approach which I accept
I see Cerillion (LON:CER) is on the list, used to be a High Flyer until recently, l don't think anything has changed apart from the share price.
Why is Contrarian a winning style? It has a poor performance.
Style Neutral is the second best performing style.
Cerillion (LON:CER)
l don't think anything has changed apart from the share price.
what is very noticeable is the expected eps growth for 2025 and 2026 - being 3% and 11%. this is much lower than historical growth in eps delivered. So on basics its no surprise that some of then premium rating may have gone on that basis alone. - looks like p/e is still 25 x - so not exactly one where you would say it is even falling into value territory. - to be fair to company it doesnt look like forecasts have been downgraded so looks like near term trading has ben reasonably out in then open for a while.
Yes that is true but it has been much more expensive in the past, l did sell most a while ago when l thought they were getting too expensive. They tend to under forecast and beat expectations. The order book seems strong, so l would not be surprised if they upgrade them. The share has risen recently, if it goes up above about 1500p, it will probably be a "high flyer" again.
Cerillion (LON:CER)
Yes that is true but it has been much more expensive in the past
Yes but if you are averaging growth in earnings of 20% plus pa (with higher historical) - you can easily justify very lofty ratings. that was the case up to 30/09/2024
for this year and next growth in earnings is nothing like the historical numbers - so on that fact alone one she be expecting the previosy lofty ratings to "perhaps" depart the scene as has happened.
Perhaps the only surprise is if the slowdown in earnings has been flagged up for some time wh the price has helf up so well until recently ?
i dont know the company well enough to know is eps growth may jump up again ? but looks like the market is simply basing valuations of the lack of growth now present - cant blame em for that if thats the reality on the ground
beating expectations is all well and good but i am minded not to presume the beat will always arrive just up just because it has in the past.
Cerillion (LON:CER), lots of insider "sells"...always a red flag for me.